CD160 and COVID-19: A very recent study has also demonstrated the expansion of NKT CD160 cluster in moderate but not severe COVID-19 patients, which was believed to promote rapid control of the disease through direct cytotoxicity as well as mediating the antibody-dependent cell-mediated cytotoxicity effect (35).